Achievements
-
.10compounds
in clinical development with the potential to become medicines for children, pregnant women and people suffering from drug-resistant malaria
-
.40chemical series
being optimized towards preclinical candidates and 3 new antimalarial candidates delivered in 2018
-
.96%reduction
in severe malaria case fatality demonstrated in a pilot project to expand access to life-saving medicine in Zambia.
Defeating malaria together
Featured resources
-
The life-saving benefits of pre-referral management
Apr 2019 -
Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum
Apr 2019 -
African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker
Apr 2019
